The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt–PCAF pathway in promotion of esophageal squamous cell carcinoma growth
Open accessAbstract
High-mobility group AT-hook 2 (HMGA2) is an architectural transcription factor that plays essential roles in embryonic development and cancer progression. However, the mechanism of HMGA2 regulation remains largely uncharacterized. Here, we demonstrate that HMGA2 can be modulated by hepatitis B X-interacting protein (HBXIP), an oncogenic transcriptional coactivator, in esophageal squamous cell carcinoma (ESCC). HMGA2 expression was positively associated with HBXIP expression in clinical ESCC tissues, and their high levels were associated with advanced tumor stage and reduced overall and disease-free survival. We found that oncogenic HBXIP could posttranslationally upregulate HMGA2 protein level in ESCC cells. HBXIP induced HMGA2 acetylation at the lysine 26 (K26), resulting in HMGA2 protein accumulation. In this process, HBXIP increased the acetyltransferase p300/CBP-associated factor (PCAF) phosphorylation and activation via the Akt pathway, then PCAF directly interacted with HMGA2, leading to HMGA2 acetylation in the cells. HMGA2 K26 acetylation enhanced its DNA binding capacity and blocked its ubiquitination and then inhibited proteasome-dependent degradation. Functionally, HBXIP-stabilized HMGA2 could promote ESCC cell growth in vitro and in vivo. Strikingly, aspirin suppressed ESCC growth by inhibiting HBXIP and HMGA2. Collectively, our findings disclose a new mechanism for the posttranslational regulation of HMGA2 mediated by HBXIP in ESCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, HMGA2 acetylation was mediated by the acetyltransferase PCAF, a downstream target of the Akt signaling pathway, demonstrating the crosstalk of acetylation-mediated degradation with phosphorylation signaling cascades [77].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The oncogenic activity of HMGA2K26Ac promotes proliferation of esophageal squamous cell carcinoma (ESCC) better than non-acetylated HMGA2 [77].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Acetylation of HMGA2 at K26 directly competes with ubiquitination, thus stabilizing HMGA2 and increasing occupancy of HMGA2 target promoter regions upstream of cyclin A and SOX2 (Figure 3A) [77].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006 · cited 3×
“The acetylation of specific lysines can increase the stability of a protein through preventing ubiquitination of the same lysine residues (47,54,55).”
BackgroundRagulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918 · cited 2×
“Mammalian hepatitis B X-interacting protein (HBXIP), also known as LAMTOR5 (22), is a conserved 18-kDa protein, which was identified initially based on its binding to the C-terminus of hepatitis B virus X proteins (23).”
BackgroundEsophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
Napier, K. J. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i5.112 · Cited by 796
p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
Roles of HMGA proteins in cancer
Fusco, A., & Fedele, M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2271 · Cited by 716
Nishino, J., Kim, I., Chada, K., & Morrison, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.017 · Cited by 627
Corley, D. A., Kerlikowske, K., Verma, R., & Buffler, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50008 · Cited by 527
Acetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
The role of aspirin in cancer prevention
Thun, M. J., Jacobs, E. J., & Patrono, C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.199 · Cited by 481
Let-7 expression defines two differentiation stages of cancer
Shell, S., Park, S.-M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., Feig, C., Lengyel, E., & Peter, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704372104 · Cited by 458
Aspirin and colorectal cancer: the promise of precision chemoprevention
Drew, D. A., Cao, Y., & Chan, A. T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.4 · Cited by 453
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Cross-regulation of histone modifications
Latham, J. A., & Dent, S. Y. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1307 · Cited by 405
Thuault, S., Tan, E.-J., Peinado, H., Cano, A., Heldin, C.-H., & Moustakas, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802016200 · Cited by 365
Zhao, D., Zou, S.-W., Liu, Y., Zhou, X., Mo, Y., Wang, P., Xu, Y.-H., Dong, B., Xiong, Y., Lei, Q.-Y., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.005 · Cited by 345
Sitia, G., Aiolfi, R., Di Lucia, P., Mainetti, M., Fiocchi, A., Mingozzi, F., Esposito, A., Ruggeri, Z. M., Chisari, F. V., Iannacone, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209182109 · Cited by 317
Caron, C., Boyault, C., & Khochbin, S. (2005) · BioEssays · doi:10.1002/bies.20210 · Cited by 291
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
Fedele, M., Visone, R., De Martino, I., Troncone, G., Palmieri, D., Battista, S., Ciarmiello, A., Pallante, P., Arra, C., Melillo, R. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.024 · Cited by 273
Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer
Sgarra, R., Rustighi, A., Tessari, M. A., Di Bernardo, J., Altamura, S., Fusco, A., Manfioletti, G., & Giancotti, V. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.013 · Cited by 228
Melegari, M., Scaglioni, P. P., & Wands, J. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1737-1743.1998 · Cited by 220
Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer
Yun, J., Frankenberger, C. A., Kuo, W., Boelens, M. C., Eves, E. M., Cheng, N., Liang, H., Li, W., Ishwaran, H., Minn, A. J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.312 · Cited by 206
Increased expression of high mobility group A proteins in lung cancer
Sarhadi, V., Wikman, H., Salmenkivi, K., Kuosma, E., Sioris, T., Salo, J., Karjalainen, A., Knuutila, S., & Anttila, S. (2006) · The Journal of Pathology · doi:10.1002/path.1960 · Cited by 184
Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
Wang, X., Liu, X., Li, A. Y.-J., Chen, L., Lai, L., Lin, H. H., Hu, S., Yao, L., Peng, J., Loera, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2542 · Cited by 184
Self-citationJohansson, L., Båvner, A., Thomsen, J. S., Färnegårdh, M., Gustafsson, J.-Α., & Treuter, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1124-1133.2000 · Cited by 175
Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardon, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M. S., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201320 · Cited by 171
Antiproliferative Effects by Let-7 Repression of High-Mobility Group A2 in Uterine Leiomyoma
Peng, Y., Laser, J. S., Shi, G., Mittal, K., Melamed, J., Lee, P., & Wei, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0370 · Cited by 166
Liao, L. M., Vaughan, T. L., Corley, D. A., Cook, M. B., Casson, A. G., Kamangar, F., Abnet, C. C., Risch, H. A., Giffen, C., Freedman, N. D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.019 · Cited by 162
Transcriptional Activation of the Cyclin A Gene by the Architectural Transcription Factor HMGA2
Tessari, M. A., Gostissa, M., Altamura, S., Sgarra, R., Rustighi, A., Salvagno, C., Caretti, G., Imbriano, C., Mantovani, R., Sal, G. D., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9104-9116.2003 · Cited by 152
HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc
Li, Y., Wang, Z., Shi, H., Li, H., Li, L., Fang, R., Cai, X., Liu, B., Zhang, X., & Ye, L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3607 · Cited by 141
Self-citationChien, C., Wang, M., Chu, P., Chang, Y.-L., Liu, W., Yu, C.-C., Lan, Y., Huang, P., Lee, Y., Chen, Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2215 · Cited by 138
Li, Y., Zhao, Z., Xu, C., Zhou, Z., Zhu, Z., & You, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.007 · Cited by 131
Cai, X., Cao, C., Li, J., Chen, F., Zhang, S., Liu, B., Zhang, W., Zhang, X., & Ye, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16873 · Cited by 111
Self-citationHu, N., Zhang, J., Cui, W., Kong, G., Zhang, S., Yue, L., Bai, X. F., Zhang, Z., Zhang, W., Zhang, X., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204131 · Cited by 109
Self-citationEpigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma
Chiou, G., Chien, C., Wang, M., Chen, M.-T., Yang, Y., Yu, Y., Chien, Y., Chang, Y., Shen, C., Chio, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.009 · Cited by 106
Summer, H., Ou, L., Bao, Q., Zhan, L., Peter, S., Sathiyanathan, P., Henderson, D., Klonisch, T. C., Goodman, S. D., & Dröge, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp375 · Cited by 99
Shen, W., Wang, C., Xia, L., Fan, C., Dong, H., Deckelbaum, R., & Qi, K.-M. (2014) · Scientific Reports · doi:10.1038/srep05282 · Cited by 96
PCAF/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair
Zhao, M., Geng, R., Guo, X. Y., Yuan, R., Zhou, X. A., Zhong, Y., Huo, Y., Zhou, M., Shen, Q., Li, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.015 · Cited by 95
Zhao, Y., Li, H., Zhang, Y., Li, L., Fang, R., Li, Y., Liu, Q., Zhang, W., Qiu, L., Liu, F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1734 · Cited by 91
Self-citationFujii, R., Zhu, C., Wen, Y., Marusawa, H., Bailly‐Maitre, B., Matsuzawa, S.-I., Zhang, H., Kim, Y. S., Bennett, C. F., Jiang, W. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1886 · Cited by 85
Langelotz, C., Schmid, P., Jakob, C., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600935 · Cited by 78
Role of Aspirin in Breast Cancer Survival
Chen, W. Y., & Holmes, M. D. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0605-6 · Cited by 77
Liu, B., Wang, T., Wang, H., Zhang, L., Xu, F., Fang, R., Li, L., Cai, X., Wu, Y., Zhang, W., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0577-5 · Cited by 73
Self-citationShan, C., Xu, F.-Q., Zhang, S., You, J., You, X., Qiu, L., Zheng, J., Ye, L., & Zhang, X. (2010) · Cell Research · doi:10.1038/cr.2010.49 · Cited by 68
Self-citationYue, L., Li, L., Liu, F., Hu, N., Zhang, W., Bai, X. F., Li, Y., Zhang, Y., Fu, L., Zhang, X., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs399 · Cited by 64
Self-citationHigh-Mobility Group A2 Protein Modulates hTERT Transcription To Promote Tumorigenesis
Li, A. Y. J., Lin, H. H., Kuo, C., Shih, H.-M., Wang, C. C. C., Yen, Y., & Ann, D. K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05447-11 · Cited by 58
Li, Y., Zhang, Z., Zhou, X., Li, L., Liu, Q., Wang, Z., Bai, X. F., Zhao, Y., Shi, H., Zhang, X., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.047 · Cited by 55
Self-citationShi, H., Fang, R., Li, Y., Li, L., Zhang, W., Wang, H., Chen, F., Zhang, S., Zhang, X., & Ye, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.025 · Cited by 52
Self-citationSong, C.-Z., Keller, K. L., Chen, Y., & Stamatoyannopoulos, G. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00429-7 · Cited by 52
Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis
Ahmed, K. M., Tsai, C. Y., & Lee, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062265 · Cited by 45
Sgarra, R., Maurizio, E., Zammitti, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr900087r · Cited by 42
Schwanbeck, R., Manfioletti, G., & Wiśniewski, J. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1793 · Cited by 42
Zhang, Y., Zhao, Y., Li, H., Li, Y., Cai, X., Shen, Y., Shi, H., Li, L., Liu, Q., Zhang, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458638 · Cited by 33
Self-citationThe oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells
Wang, Y., Cui, M., Cai, X., Sun, B., Liu, F., Zhang, X., & Ye, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.007 · Cited by 33
Self-citationHMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
Palumbo, A., Costa, N. M. D., Esposito, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8288 · Cited by 33
Liu, X., Xiao, W., Wang, X., Li, Y., Han, J., & Li, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486910 · Cited by 31
Self-citationLi, L., Liu, B., Zhang, X., & Ye, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.036 · Cited by 29
Self-citationHuang, C., Zhang, Z., Chen, L., Lee, H. W., Ayrapetov, M. K., Zhao, T. C., Hao, Y., Gao, J., Yang, C., Mehta, G. U., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2314 · Cited by 24
SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome
Cao, X., Clavijo, C. A., Li, X., Lin, H. H., Chen, Y., Shih, H.-M., & Ann, D. K. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0540 · Cited by 20
Xia, H., Ma, L., Li, J., Bai, H., & Wang, D. (2017) · Europe PMC (PubMed Central) · Cited by 10
Cited by
Sun, X., Zhang, K., Peng, X., Zhou, P., Qu, C., Yang, L., & Shen, L. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216158 · Cited by 21
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Metadata
- Authors
- Wu, Y., Wang, X., Xu, F., Zhang, L., Wang, T., Fu, X., Jin, T., Zhang, W., & Ye, L.
- Affiliations
- Nankai University (CN)
- Corresponding author
- Ye, Lihong
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-20
- Volume
- 48
- Issue
- 9
- Pages
- 4858-4876
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7229824
- OpenAlex
- W3017157136
- Cited by
- 47
- References
- 61
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 3
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Basic Research Program of China (2015CB553905)
- National Natural Science Foundation of China (31670771, 31870752)
- Fundamental Research Funds for the Central Universities
- Ph.D. Candidate Research Innovation Fund of Nankai University
- Project of Prevention and Control of Key Chronic Non-Infectious Diseases (2016YFC1303401)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HMGA2, HBXIP, esophageal squamous cell carcinoma, protein acetylation, PCAF, Akt signaling, protein stability, ubiquitination, proteasomal degradation, transcriptional coactivator, aspirin, tumor growth
- MeSH terms
- Esophageal Squamous Cell Carcinoma, p300-CBP-Associated Factor, Acetylation, Animals, Aspirin, DNA, Esophageal Neoplasms, Female, Humans, Lysine, Mice, Inbred BALB C, Mice, Nude, Prognosis, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, HMGA2 Protein, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, p300-CBP Transcription Factors, Proto-Oncogene Proteins c-akt, Ubiquitination, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.